Amneal Pharmaceuticals, Inc. (AMRX)
17.78
-0.13
(-0.73%)
USD |
NASDAQ |
Aug 24, 16:00
17.77
-0.01
(-0.06%)
After-Hours: 20:00
Amneal Pharmaceuticals Total Liabilities (Quarterly) : 3.659B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.659B |
| March 31, 2026 | 3.500B |
| December 31, 2025 | 3.672B |
| September 30, 2025 | 3.642B |
| June 30, 2025 | 3.470B |
| March 31, 2025 | 3.425B |
| December 31, 2024 | 3.546B |
| September 30, 2024 | 3.495B |
| June 30, 2024 | 3.514B |
| March 31, 2024 | 3.473B |
| December 31, 2023 | 3.411B |
| September 30, 2023 | 3.496B |
| June 30, 2023 | 3.518B |
| March 31, 2023 | 3.464B |
| December 31, 2022 | 3.590B |
| September 30, 2022 | 3.657B |
| June 30, 2022 | 3.851B |
| March 31, 2022 | 3.465B |
| December 31, 2021 | 3.556B |
| September 30, 2021 | 3.576B |
| June 30, 2021 | 3.619B |
| March 31, 2021 | 3.580B |
| December 31, 2020 | 3.649B |
| September 30, 2020 | 3.677B |
| June 30, 2020 | 3.673B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.975B |
| December 31, 2019 | 3.319B |
| September 30, 2019 | 3.308B |
| June 30, 2019 | 3.513B |
| March 31, 2019 | 3.585B |
| December 31, 2018 | 3.456B |
| September 30, 2018 | 3.667B |
| June 30, 2018 | 3.593B |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 1.717B |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | 1.155B |
| December 31, 2016 | 1.199B |
| September 30, 2016 | 1.216B |
| June 30, 2016 | 776.55M |
| March 31, 2016 | 816.87M |
| December 31, 2015 | 860.08M |
| September 30, 2015 | 967.21M |
| June 30, 2015 | 1.045B |
| March 31, 2015 | 887.94M |
| December 31, 2014 | 192.41M |
| September 30, 2014 | 203.67M |
| June 30, 2014 | 189.82M |
| March 31, 2014 | 157.02M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Liquidia Corp. | 326.80M |
| Eli Lilly & Co. | 108.40B |
| Indivior Pharmaceuticals, Inc. | 1.441B |
| Viatris, Inc. | 20.78B |
| Pfizer Inc. | 115.64B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.776B |
| Shareholders Equity (Quarterly) | 33.02M |
| Debt to Equity Ratio | 84.54 |
| Current Ratio | 2.204 |
| Net Debt Paydown Yield | -0.77% |